(Q46017035)
Statements
1 reference
Valganciclovir as CMV reactivation prophylaxis in patients receiving alemtuzumab for marrow failure syndromes. (English)
1 reference
Bruno Rotoli
1 reference
Carmine Selleri
1 reference
Bianca Serio
1 reference
Antonio M Risitano
1 reference
9 May 2009
1 reference
1 reference
88
1 reference
12
1 reference
1261-1262
1 reference
Identifiers
1 reference